Moringa Isothiocyanates and Inflammation

If you strip away the superfood marketing, one genuinely interesting thing remains in this plant, and it is not a vitamin. It is a sulfur compound called moringin, and it is moringa’s answer to sulforaphane — the much-studied molecule from broccoli sprouts.

This is the part of moringa that serious chemists and pharmacologists actually work on. It has a defined molecule, a defined enzyme that makes it, a defined cellular target, and a body of reproducible laboratory work behind it. It is the strongest mechanistic story moringa has.

It also has a hard limit that you should know before reading any further: there are no human clinical trials of moringa isothiocyanates with health endpoints. Everything below is cell culture and animal work. And there is a second, more practical problem — the bag of moringa powder in your kitchen very likely contains almost none of this compound, for reasons that are entirely predictable once you understand how it is made.

Table of Contents

  1. The Family Resemblance to Broccoli
  2. Glucomoringin: The Unusual Sugar
  3. How Moringin Actually Gets Made
  4. Why the Rhamnose Matters
  5. Nrf2 and the Indirect Antioxidant Idea
  6. What the Preclinical Work Shows
  7. The Gap: No Human Endpoints
  8. Why Your Powder Probably Has None
  9. Getting Isothiocyanates If You Want Them
  10. Cautions
  11. Key Research Papers
  12. Connections

The Family Resemblance to Broccoli

Broccoli, cabbage, kale, mustard, horseradish, wasabi and watercress all belong to a group of plants that make glucosinolates — sulfur-and-nitrogen compounds that sit inertly in plant cells until the tissue is damaged. Bite into a radish and the sharp heat that hits the back of your nose a second later is a glucosinolate being converted, in real time, into an isothiocyanate. It is a chemical defence system: harmless while the plant is intact, pungent and reactive the moment something chews on it.

Moringa is not a brassica — it belongs to its own small family, the Moringaceae — but it independently evolved the same chemistry. That is why it is called the horseradish tree: crush the root and you get the same pungency, from the same class of molecule.

The comparison worth holding on to is with broccoli. Broccoli stores glucoraphanin, which converts to sulforaphane, the compound behind thousands of papers on cellular stress defence. Moringa stores glucomoringin, which converts to moringin. Same family of chemistry, same general mechanism, one important structural difference — and vastly less human research.

Glucomoringin: The Unusual Sugar

Moringa’s principal glucosinolate has a name that tells you exactly what makes it odd: 4-(α-L-rhamnopyranosyloxy)benzyl glucosinolate, mercifully abbreviated to glucomoringin.

The unusual part is the rhamnose — a sugar bolted onto the molecule that almost no other glucosinolate carries. Surveys of glucosinolate chemistry across the Moringaceae family have documented these rhamnose-substituted glucosinolates as a distinguishing feature of the group, with content varying considerably between species and between tissues of the same plant. Seeds are generally the richest source; leaves carry meaningful amounts; roots and bark carry them too, along with the alkaloids that make root preparations unsafe.

Analytical profiling across moringa tissues has mapped both the glucosinolates and the accompanying phenolics, and mass-spectrometry work has confirmed the structures. This is not folklore chemistry — the molecules are characterised, and the variability between samples is documented rather than glossed over.

How Moringin Actually Gets Made

Glucomoringin on its own does essentially nothing biologically. It needs to be cut.

The plant keeps an enzyme called myrosinase physically separated from its glucosinolates inside intact tissue. Crush, chew, chop or blend the tissue and the two meet. Myrosinase cleaves the glucose off glucomoringin, and the remaining fragment rearranges into moringin — 4-(α-L-rhamnopyranosyloxy)benzyl isothiocyanate, which appears in the literature as MIC-1 or 4-RBITC.

Three consequences follow from this, and they explain most of what is confusing about moringa supplements:

  1. Damage is required. Whole, undamaged leaf yields nothing. The conversion begins when the tissue is broken.
  2. Myrosinase is a protein, so heat destroys it. Blanch the leaves, dry them at high temperature, or cook the powder into a boiling pot, and the enzyme is gone. The glucosinolate may survive; the machinery that activates it does not.
  3. Isothiocyanates are reactive, so they do not last forever. If the conversion happened months ago during processing, the product may have degraded before it reached you.

Researchers building an isothiocyanate-rich moringa seed extract exploited step one deliberately: they ground the seeds and incubated them with water, letting the plant’s own myrosinase do the work, and optimised the process until the extract was 38.9% MIC-1. That is a laboratory procedure, not something happening in a commercial drying shed.

Why the Rhamnose Matters

Here is where moringin is genuinely more interesting than a broccoli knock-off.

Sulforaphane is notoriously awkward to work with: poorly water-soluble and unstable, degrading in aqueous solution. That instability is a real obstacle to using it as a nutrient or a drug.

Moringin’s attached rhamnose sugar changes its physical behaviour. The molecule is water-soluble and comparatively stable in water — the paper that first characterised the leaf isothiocyanates put “stable, water extractable” right in its title, because that is the finding. Practically, it means moringin can be extracted into a simple aqueous preparation — a tea — and survive there, which sulforaphane largely cannot.

That property is why a Johns Hopkins group built and published standardised aqueous moringa “teas” specifically designed to deliver precisely calibrated doses of glucomoringin and moringin for use in clinical studies. Note what that paper implies: as of its publication, nobody could reliably dose humans with these compounds, and building a way to do it was itself the contribution. That is the honest state of the field.

Nrf2 and the Indirect Antioxidant Idea

Isothiocyanates do not work the way the word “antioxidant” on a supplement bottle suggests. They are not sponges that soak up free radicals. They are electrophiles — mildly reactive molecules that chemically modify specific cysteine residues on a sensor protein called Keap1.

Under normal conditions Keap1 grabs a transcription factor called Nrf2 and marks it for destruction, so very little Nrf2 reaches the nucleus. When an isothiocyanate modifies Keap1, that grip fails. Nrf2 escapes, enters the nucleus, and switches on a coordinated battery of genes: glutathione synthesis, glutathione S-transferases, NAD(P)H quinone oxidoreductase, heme oxygenase-1 and others. The cell does not receive an antioxidant; it is instructed to build its own.

This is called indirect antioxidant action, and it has two advantages over swallowing an antioxidant molecule. The response is catalytic — a small trigger produces a large, enzyme-mediated effect — and it is durable, lasting as long as the induced enzymes do rather than as long as the molecule circulates.

Alongside Nrf2 activation, isothiocyanates suppress NF-κB signalling, the master switch for inflammatory gene expression. In the moringa work this shows up as reduced production of nitric oxide and reduced expression of inducible nitric oxide synthase, interleukin-1β and interleukin-6 in stimulated immune cells.

What the Preclinical Work Shows

Every study below is cell culture or animal. None involves a human clinical endpoint. Read them as biology, not as evidence of benefit.

Inflammation in cells

Water-extractable isothiocyanates from moringa leaves reduced inflammatory signalling in cultured macrophages — the paper that established both their stability and their activity. In a separate line of work, purified MIC-1 reduced nitric oxide production at a concentration of 1 micromolar and suppressed the gene expression of iNOS, IL-1β and IL-6 at 5 micromolar. These are low concentrations, which is the point: the compound is potent, not merely present.

A head-to-head against curcumin

The same group ran a comparison that rarely gets mentioned in moringa marketing, probably because it is unusually direct. They tested an isothiocyanate-enriched moringa seed extract against a curcuminoid-enriched turmeric extract and a further curcumin-enriched material, in the carrageenan-induced rat paw oedema model — a standard test of acute anti-inflammatory activity.

The moringa extract reduced swelling by 33% at 500 mg/kg of MIC-1, comparable to aspirin’s 27% at 300 mg/kg. The turmeric extract produced no significant effect at all. In cells, MIC-1 also upregulated Nrf2 more effectively than the curcumin material, which showed no significant activity at any concentration tested.

Two honest readings of that. It is a genuine point in moringa’s favour: in this model, its isothiocyanate beat the most famous anti-inflammatory botanical on the market. And it is a caution about botanical enthusiasm generally: curcumin has an enormous reputation and it did nothing here, which should temper how much weight anyone puts on reputation.

Metabolic effects in mice

Mice on a very high-fat diet supplemented with a moringa concentrate delivering roughly 66 mg/kg/day of moringa isothiocyanates accumulated less fat, had better glucose tolerance and insulin signalling, and did not develop fatty liver disease compared with high-fat-fed controls. Their plasma insulin, leptin, resistin, cholesterol, IL-1β and TNFα were all lower. In liver cells, the isothiocyanates directly inhibited gluconeogenesis and suppressed glucose-6-phosphatase — a rate-limiting enzyme in the liver’s glucose production. The authors concluded the isothiocyanates, not the leaf’s other constituents, were the main active fraction.

That last conclusion matters. It means the metabolic activity people attribute to “moringa” may belong to a specific compound that ordinary leaf powder does not reliably contain — which would neatly explain why the human trials of leaf powder in Blood Sugar and Cholesterol have been so unimpressive.

Neuroinflammation and antimicrobial activity

Moringin has been tested in a mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis), where it activated the canonical Wnt pathway by inhibiting GSK3β. Glucomoringin activated with myrosinase has shown antibacterial activity against pathogens relevant to long-stay hospital patients. A related moringa thiocarbamate, niaziminin, was found to inhibit tumour-promoter-induced Epstein-Barr virus activation, with a strict structural requirement — small changes to the molecule abolished the effect, which is the signature of a specific interaction rather than a nonspecific one.

The Gap: No Human Endpoints

Put all of that together and you have a compound with a characterised structure, a known activating enzyme, a defined molecular target, potency in the low micromolar range, activity in several animal models, and a favourable comparison against a famous competitor.

You also have zero randomised controlled trials showing that consuming moringa reduces inflammation-driven disease in a person.

That is not a technicality. The history of nutritional pharmacology is substantially a history of compounds that looked exactly this good in a dish and then failed to translate — because absorption was poor, because the human dose was unreachable, because the animal model did not represent the human disease, or because the effect was real but too small to matter. Sulforaphane itself, with a research literature many times larger than moringin’s, still has a modest and contested clinical record.

So the correct summary is: mechanistically strong, clinically untested. That is a genuinely interesting position for a compound to be in. It is not the same as a benefit.

Why Your Powder Probably Has None

Here is the practical problem, and it is the reason this whole section may be irrelevant to the bag in your cupboard.

  1. Content varies enormously. Glucosinolate levels differ by moringa species, cultivar, plant tissue, growing conditions and leaf age. Two bags of powder can differ severalfold, and neither will say so.
  2. Myrosinase is heat-labile. Commercial leaf is frequently blanched or heat-dried. If the enzyme was destroyed, glucomoringin sits there unconverted — and unconverted glucosinolate is not the active compound.
  3. Or the conversion already happened, months ago. If the leaf was crushed damp and left, myrosinase may have done its job during processing, and the reactive isothiocyanate has had a long time to degrade in a warehouse.
  4. Nobody measures it. No mainstream retail moringa product declares its glucomoringin or moringin content. You cannot know what you bought, and neither can the seller.
  5. The researchers had to build a workaround. The standardised-tea paper exists because delivering a known dose to a person was, and largely still is, an unsolved problem outside a laboratory.

There is one partial rescue. For broccoli it is well established that when plant myrosinase has been destroyed by cooking, the gut microbiota can perform some of the conversion in the colon, producing sulforaphane from glucoraphanin at a lower and highly person-dependent yield. It is reasonable to expect something similar for glucomoringin, though this is much less studied. Treat it as a plausible partial rescue with a variable and unknown yield — not as a reason to assume your powder is working.

Getting Isothiocyanates If You Want Them

None of the following is validated by a human trial. These are reasonable inferences from the chemistry, offered as such.

Cautions

Reactivity cuts both ways. Isothiocyanates work precisely because they are electrophiles that modify protein cysteines. That is a useful property at the low concentrations that trigger Nrf2, and it is not automatically benign at high concentrations, where the same reactivity hits proteins you did not intend. “More isothiocyanate” is not a safe scaling rule, and the mouse dose above is far higher than any culinary exposure.

Thyroid — the most specific concern in this section. Glucosinolate breakdown can yield thiocyanate ion, which competes with iodide for uptake into the thyroid gland through the sodium-iodide symporter. This is the long-established basis for the goitrogenic reputation of brassica vegetables when eaten in very large amounts on a low-iodine diet. Independently, moringa leaf extract shifted circulating thyroid hormone levels in rats. Two separate lines of evidence pointing at the same organ is worth respecting: if you take levothyroxine or are treated for a thyroid disorder, tell your prescriber about regular moringa use and have your levels checked. Adequate dietary iodine matters here too.

Root and root bark: avoid. The root is the most pungent part of the plant precisely because its isothiocyanate chemistry is concentrated there — but it also concentrates alkaloids, including the compound described in older Indian pharmacological literature as spirochin, and analytical work has documented much higher anti-nutritional content in root than leaf. Root has a traditional use as an abortifacient. The pungency is not a sign of a stronger supplement; it comes packaged with the part of the plant you should not eat.

Pregnancy. Avoid root, bark and concentrated extracts outright. Concentrated isothiocyanate preparations have no pregnancy safety data at all.

Concentrated seed extracts. Seeds are the richest glucosinolate source, which makes seed extract the obvious commercial target — and rodent studies of moringa preparations at supra-supplementation doses have shown toxicity signals. A few roasted seeds as a snack is a different thing from a concentrated extract taken daily.

Blood-thinning and other medication. Nrf2-activating compounds influence phase II drug-metabolising enzymes, which is a theoretical route to altering drug clearance. This has not produced a documented clinical problem with moringa, but it is a reason to mention regular high-dose use to a pharmacist if you take narrow-margin medication.

Key Research Papers

Every identifier below was verified live against NCBI E-utilities before it was printed — first author, title, journal and year all had to match. Every finding here is cell culture or animal; none is a human clinical endpoint.

  1. Waterman C, Cheng DM, Rojas-Silva P, et al. Stable, water extractable isothiocyanates from Moringa oleifera leaves attenuate inflammation in vitro. Phytochemistry. 2014;103:114–122. Cell. Established both the stability and the anti-inflammatory activity of the leaf isothiocyanates.
  2. Jaja-Chimedza A, Graf BL, Simmler C, et al. Biochemical characterization and anti-inflammatory properties of an isothiocyanate-enriched moringa (Moringa oleifera) seed extract. PLoS One. 2017;12(8):e0182658. Cell and animal. The 38.9% MIC-1 extract, the rat paw oedema result, and the head-to-head against curcumin.
  3. Waterman C, Rojas-Silva P, Tumer TB, et al. Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice. Molecular Nutrition & Food Research. 2015;59(6):1013–1024. Animal and cell. Roughly 66 mg/kg/day of isothiocyanates; identifies them as the main active fraction.
  4. Fahey JW, Olson ME, Stephenson KK, et al. The diversity of chemoprotective glucosinolates in Moringaceae (Moringa spp.). Scientific Reports. 2018;8(1):7994. Documents how much glucosinolate content varies across species and tissues.
  5. Fahey JW, Wade KL, Stephenson KK, et al. A strategy to deliver precise oral doses of the glucosinolates or isothiocyanates from Moringa oleifera leaves for use in clinical studies. Nutrients. 2019;11(7):1547. Exists because precise human dosing was an unsolved problem.
  6. Bennett RN, Mellon FA, Foidl N, et al. Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (horseradish tree) and Moringa stenopetala L. Journal of Agricultural and Food Chemistry. 2003;51(12):3546–3553. The tissue-by-tissue map.
  7. Maldini M, Maksoud SA, Natella F, et al. Moringa oleifera: study of phenolics and glucosinolates by mass spectrometry. Journal of Mass Spectrometry. 2014;49(9):900–910.
  8. Giacoppo S, Iori R, Bramanti P, Mazzon E. Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis. Drug Design, Development and Therapy. 2016;10:3291–3304. Animal. A model of multiple sclerosis, not a trial in people with MS.
  9. Galuppo M, Nicola GD, Iori R, Dell’Utri P, Bramanti P, Mazzon E. Antibacterial activity of glucomoringin bioactivated with myrosinase against two important pathogens affecting the health of long-term patients in hospitals. Molecules. 2013;18(11):14340–14348. Cell. Note the design: glucomoringin had to be activated with myrosinase to work.
  10. Murakami A, Kitazono Y, Jiwajinda S, Koshimizu K, Ohigashi H. Niaziminin, a thiocarbamate from the leaves of Moringa oleifera, holds a strict structural requirement for inhibition of tumor-promoter-induced Epstein-Barr virus activation. Planta Medica. 1998;64(4):319–323. Cell.
  11. Eilert U, Wolters B, Nahrstedt A. The antibiotic principle of seeds of Moringa oleifera and Moringa stenopetala. Planta Medica. 1981;42(1):55–61. The early identification of the benzyl isothiocyanate chemistry behind moringa’s antimicrobial reputation.
  12. Saini RK, Sivanesan I, Keum YS. Phytochemicals of Moringa oleifera: a review of their nutritional, therapeutic and industrial significance. 3 Biotech. 2016;6(2):203.
  13. Tahiliani P, Kar A. Role of Moringa oleifera leaf extract in the regulation of thyroid hormone status in adult male and female rats. Pharmacological Research. 2000;41(3):319–323. Animal. One of the two independent lines of evidence behind the thyroid caution.
  14. Thiocyanate from glucosinolate breakdown, iodide competition at the sodium-iodide symporter, and the goitrogenic potential of brassica-type vegetables. PubMed search.
  15. Gut microbiota conversion of glucosinolates to isothiocyanates when plant myrosinase has been destroyed by cooking. PubMed search.

Live PubMed Searches

  1. Glucomoringin
  2. Moringin
  3. Moringa and Nrf2
  4. Moringa and NF-κB
  5. Isothiocyanates and Keap1
  6. Sulforaphane clinical trials — the comparison case
  7. Myrosinase heat inactivation
  8. Glucosinolate stability during processing

Connections

Back to Table of Contents